4530 — Hisamitsu Pharmaceutical Co Balance Sheet
0.000.00%
- ¥286bn
- ¥178bn
- ¥156bn
- 94
- 54
- 35
- 69
Annual balance sheet for Hisamitsu Pharmaceutical Co, fiscal year end - February 28th, JPY millions except per share, conversion factor applied.
2021 February 28th | 2022 February 28th | 2023 February 28th | 2024 February 29th | 2025 February 28th | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | Yuho | Yuho | Yuho | Yuho | Yuho |
| Standards: | JAS | JAS | JAS | JAS | JAS |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 135,997 | 142,431 | 136,868 | 125,321 | 129,116 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 39,203 | 38,112 | 39,753 | 42,983 | 46,879 |
| Total Inventory | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 198,061 | 200,176 | 199,174 | 194,022 | 203,788 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 37,354 | 39,069 | 43,209 | 49,462 | 59,899 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 299,861 | 302,858 | 313,917 | 328,779 | 343,068 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 30,057 | 32,160 | 42,578 | 45,938 | 47,226 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 47,562 | 49,690 | 57,551 | 63,902 | 66,242 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Unrealized Gain / Loss | |||||
| Other Equity | |||||
| Total Equity | 252,299 | 253,168 | 256,366 | 264,877 | 276,826 |
| Total Liabilities & Shareholders' Equity | 299,861 | 302,858 | 313,917 | 328,779 | 343,068 |
| Total Common Shares Outstanding |